GLP-1 Medications, Like Ozempic, May Help To Slow Or Even Reverse Aging According To New Study
Shutterstock GLP-1 drugs such as Ozempic have been shown to be extremely effective at helping diabetics manage their blood sugar, and almost anyone else to lose weight and keep it off. These drugs have also been shown to help stop addictions of all types in many people. A new study performed by TruDiagnostic has one […]
STAT+: Pharmalittle: We’re reading about a new Trump drug-pricing probe, Novo’s board shake-up, and more
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we are firing up the coffee kettle and invite you […]
STAT+: Novo Foundation ousts board in power struggle
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Today, we talk about how startups are looking for new ways to price drugs, particularly GLP-1s, see how tracking circulating tumor DNA holds promise in cancer treatment, and more. The need-to-know this morning […]
Why Everything From Perfume to Soap Smells Like Food Now
As demand for products scented like vanilla, pistachio and other edible indulgences soars, some GLP-1 users say there’s a link to their changed eating habits.
Among T2D Drugs, GLP-1s Top Others for Reducing CV Events
A comparative effectiveness study of glucose-lowering drugs finds the GLP-1 receptor agonists most protective against cardiovascular events, followed by SGLT2i and two older drug classes. Medscape Medical News
More and more workers are using weight loss drugs. It’s costing their employers a fortune – CNN
More and more workers are using weight loss drugs. It’s costing their employers a fortune CNN Ozempic for All The Atlantic Lopez: Expanding access to anti-obesity drugs a win-win Boston Herald What To Do When Insurance Won’t Cover Your GLP-1 Prescription NewBeauty Perspectives from Employers on the Costs and Issues Associated with Covering GLP-1 Agonists for Weight Loss KFF
STAT+: Companies tout a novel payment model for obesity drugs, other medications in drive to lower costs
As pharma companies and President Trump tout initiatives to sell branded medications directly to cash-paying consumers, some entrepreneurs have seized on a potential business opportunity — pitching a new model for employers to help their workers pay for medications without using insurance. Take the blockbuster obesity treatments Wegovy and Zepbound, for example. Many employers don’t […]
Coke Is Leaning Into the Protein Craze as It Lands in More Drinks, Snacks—and Pet Foods
Beata Zawrzel / NurPhoto via Getty Images Coca-Cola is ramping up production of high-protein milks. Key Takeaways Coca-Cola is leaning into its high-protein milk products, but also planning to shake up the segment’s offerings as competition in the space heats up. Many food and beverage companies are focused on protein as a greater share of […]
GLP-1 Drugs Tied to Lower Risk of Legal Blindness in People With Diabetes
(MedPage Today) — ORLANDO — Adding another twist to the ongoing debate about the effects of weight-loss drugs on vision, a retrospective cohort study linked GLP-1 receptor agonists to a lower risk of legal blindness in patients with type 2…
Healthy Returns: A key step forward for Novo Nordisk’s GLP-1 pill
A closely watched pill from Novo Nordisk just scored an approval for slashing cardiovascular risks, while Mark Cuban gives Trump credit on drug prices.